GENMARK DIAGNOSTICS INC's ticker is GNMK and the CUSIP is 372309104.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $2,266,000 | -46.4% | 94,805 | -67.2% | 0.00% | -50.0% |
| Q4 2020 | $4,226,000 | +16.4% | 289,466 | +13.2% | 0.00% | 0.0% |
| Q3 2020 | $3,632,000 | +108.4% | 255,818 | +115.9% | 0.00% | +100.0% |
| Q2 2020 | $1,743,000 | +52.8% | 118,477 | -56.7% | 0.00% | +100.0% |
| Q4 2017 | $1,141,000 | -57.2% | 273,636 | -1.2% | 0.00% | -50.0% |
| Q3 2017 | $2,667,000 | -16.7% | 276,935 | +2.4% | 0.00% | -33.3% |
| Q2 2017 | $3,200,000 | -0.8% | 270,466 | +7.5% | 0.00% | 0.0% |
| Q1 2017 | $3,226,000 | +7.8% | 251,624 | +2.9% | 0.00% | 0.0% |
| Q4 2016 | $2,993,000 | -10.4% | 244,550 | -13.6% | 0.00% | 0.0% |
| Q3 2016 | $3,340,000 | +43.6% | 283,056 | +25.9% | 0.00% | 0.0% |
| Q2 2013 | $2,326,000 | – | 224,799 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 3,365,000 | $16,186,000 | 1.49% |
| CADIAN CAPITAL MANAGEMENT, LP | 5,517,767 | $26,540,000 | 1.17% |
| NEEDHAM INVESTMENT MANAGEMENT LLC | 1,590,000 | $7,646,000 | 1.04% |
| Parkman Healthcare Partners LLC | 420,000 | $2,020,000 | 0.58% |
| Penn Capital Management Company, LLC | 977,526 | $4,702,000 | 0.49% |
| Bullseye Asset Management LLC | 79,272 | $381,000 | 0.37% |
| Bellevue Group AG | 2,441,241 | $11,742,000 | 0.19% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 300,783 | $1,447,000 | 0.18% |
| Granite Investment Partners, LLC | 589,313 | $2,835,000 | 0.13% |
| WRAPMANAGER INC | 68,163 | $328,000 | 0.10% |